Evaluation of the Immunogenicity and Biological Activity of theCitrobacter freundiiVi-CRM197Conjugate as a Vaccine forSalmonella entericaSerovar Typhi

Population impact of Vi capsular polysaccharide vaccine

(2010) M Imran Khan et al.   Expert Review of Vaccines

Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi

(2010) F. Micoli et al.   VACCINE

A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents

(2009) Lisa A. Jackson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

a study of typhoid fever in five Asian countries: disease burden and implications for controls

(2008) R Leon Ochiai   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants

(2008) Matthew D. Snape et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor

(2008) Hyun Jang et al.   JOURNAL OF BIOTECHNOLOGY

Immune responses to polysaccharides: Lessons from humans and mice

(2007) África González-Fernández et al.   VACCINE